OTC · Medical - Pharmaceuticals

Botanix Pharmaceuticals Limited (BXPHF) Stock

$0.02 -30.23% OTC: BXPHF Healthcare

Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older.

Valuation

MetricValue
Price$0.02
Market Cap$29.89M
P/E Ratio-0.41
P/B Ratio0.69
P/S Ratio1.73
EPS (TTM)$-0.05
52-Week High$0.14
52-Week Low$0.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-131.13%
ROA-89.99%
ROCE-117.65%
Gross Margin-118.23%
Operating Margin-380.62%
Net Margin-404.72%
Debt/Equity0.57
Current Ratio2.56

Annual Financials (USD)

Metric20212022202320242025
Revenue$7.0M$3.0M$4.0M$2.0M$6.0M
Operating Profit$-9.0M$-22.0M$-14.0M$-15.0M$-86.0M
Net Profit$-3.0M$-13.0M$-9.0M$-14.0M$-86.0M
EPS$0.00$-0.01$-0.01$-0.01$-0.05
Op Margin-137.2%-814.8%-360.9%-747.0%-1499.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$22.0M$14.0M$25.0M$112.0M$129.0M
Total Liabilities$1.0M$6.0M$2.0M$4.0M$48.0M
Cash$22.0M$7.0M$10.0M$79.0M$65.0M
Borrowings$0$0$0$0$32.0M

Latest News

Piramal Pharma Solutions Announces Partnership with Botanix to Support Drug Substance Development PR Newswire · May 18, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-3.0M$-11.0M$-12.0M$-8.0M$-79.0M
Investing Cash Flow$0$-6.0M$-14.0M$-36.0M$-2.0M
Financing Cash Flow$0$0$0$-6.0M$-3.0M
Net Cash Flow$-3.0M$-14.0M$3.0M$69.0M$-14.0M
Free Cash Flow$-3.0M$-14.0M$-19.0M$-26.0M$-80.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.45
FCF Yield-213.60%
Quick Ratio1.56
Interest Coverage-12.02
Return 1Y-89.38%
Return 3Y-87.18%
Return 5Y—

Ownership

Insiders Held9.60%
Institutions Held10.09%
Institutions Float Held11.16%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAWHAscend Wellness Holdings, Inc. $0.39 -4.77% -0.60 $78.17M 0.00%
BRIBFBrii Biosciences Limited $0.13 +0.00% -2.71 $90.69M 0.00%
HOFBFHofseth BioCare ASA $0.17 +0.00% -3.90 $68.47M 0.00%
IPHYFInnate Pharma S.A. $1.65 +0.00% -2.84 $154.94M 0.00%
JWCTFJW (Cayman) Therapeutics Co. Ltd $0.20 +0.00% -1.05 $84.22M 0.00%

About Botanix Pharmaceuticals Limited

Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1801 for treating staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 for the treatment of papulopustular rosacea; and BTX 1204A for treating atopic dermatitis. The company was incorporated in 1984 and is based in West Perth, Australia.

Botanix Pharmaceuticals Limited is headquartered in AU.

Botanix Pharmaceuticals Limited (BXPHF) stock trades at $0.02 with a market capitalization of $29.89M. The stock is valued at a price-to-earnings (P/E) ratio of -0.41, price-to-book of 0.69, price-to-sales of 1.73. Over the past 52 weeks the stock has ranged between $0.01 and $0.14, and currently trades 85.7% below its 52-week high.

On profitability, Botanix Pharmaceuticals Limited generates a return on equity (ROE) of -131.13%, return on capital employed of -117.65%, an operating margin of -380.62%, a net profit margin of -404.72%.

Official website: www.botanixpharma.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides